"Circulating Tumor Cells, from biotech innovation to clinical utility" provides an overview of the most recent technological and clinical advances with regards to the study of circulating tumor cells (CTCs) in solid tumors. The volumes cover studies on CTCs in breast, prostate, colorectal and lung cancer, with a focus on clinical utility, and also include methodological and biological topics such as CTC culture, multi-omic characterization of CTCs, atypical CTC populations and interaction between CTCs and immunity.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Circulating tumor cells: from biotech innovation to clinical utility - p. iii 8. Chapter One: Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer - p. 1 9. Chapter Two: Can we define breast cancer HER2 status by liquid biopsy? - p. 24 10. Chapter Three: Models to study CTCs and CTC culture methods - p. 58 11. Chapter Four: Settling the uncertainty about unconventional circulating tumor cells: Epithelial-to-mesenchymal transition, cell fusion and trogocytosis - p. 98 12. Chapter Five: Circulating tumor cells in cancer-risk populations as a cancer interception tool - p. 114 13. Chapter Six: Circulating tumor cells and host immunity: A tricky liaison - p. 129
"Circulating Tumor Cells, from biotech innovation to clinical utility" provides an overview of the most recent technological and clinical advances with regards to the study of circulating tumor cells (CTCs) in solid tumors. The volumes cover studies on CTCs in breast, prostate, colorectal and lung cancer, with a focus on clinical utility, and also include methodological and biological topics such as CTC culture, multi-omic characterization of CTCs, atypical CTC populations and interaction between CTCs and immunity.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Circulating tumor cells: from biotech innovation to clinical utility - p. iii 8. Chapter One: Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer - p. 1 9. Chapter Two: Can we define breast cancer HER2 status by liquid biopsy? - p. 24 10. Chapter Three: Models to study CTCs and CTC culture methods - p. 58 11. Chapter Four: Settling the uncertainty about unconventional circulating tumor cells: Epithelial-to-mesenchymal transition, cell fusion and trogocytosis - p. 98 12. Chapter Five: Circulating tumor cells in cancer-risk populations as a cancer interception tool - p. 114 13. Chapter Six: Circulating tumor cells and host immunity: A tricky liaison - p. 129
